treatment guidelines

Research in Review

Proton Pump Inhibitors May Decrease Survival for Patients With Gastric Cancer

12/19/2016

JCP Editors

Over-the-counter heartburn and gastrointestinal drugs, such as proton pump inhibitors (PPIs), may decrease the effectiveness of chemotherapy in patients with gastroesophageal cancer (GEC), according to a new study...

...

12/19/2016

Journal of Clinical Pathways

Research in Review

Menopausal Symptoms Wrongly Attributed to Tamoxifen Dampen Adherence Rates

12/13/2016

JCP Editors

Menapausal symptoms experienced by women with breast cancer that were wrongly attributed to side effects of tamoxifen treatment had a dampening effect on medication adherence, according to a new...

...

12/13/2016

Journal of Clinical Pathways

Research in Review

Few RCTs of New Systemic Therapies Met ESMO Guidelines for Meaningful Outcomes

12/13/2016

JCP Editors

Fewer than one-third of randomized controlled trials reporting statistically significant outcomes for novel systemic therapies in solid cancers met the European Society of Medical Oncology’s (ESMO) threshold for...

Fewer...

12/13/2016

Journal of Clinical Pathways

Research in Review

HC-Based Next-Gen Sequencing Aids Treatment Decisions in Lung Cancer

11/23/2016

JCP Editors

Hybrid capture (HC)-based next-generation sequencing (NGS) can identify targetable oncogenic drivers to improve response rates in patients with lung cancer, according to a study published in the Journal of Thoracic...

Hybrid...

11/23/2016

Journal of Clinical Pathways

Research in Review

Testing for PD-L1 Expression to Determine Lung Cancer Treatment

11/17/2016

JCP Editors

Using PD-L1 expression to determine non-small cell lung cancer (NSCLC) treatment is becoming standard of care, according to a presentation given at the 11th Annual New York Lung Cancer Symposium (November 12,...

Using...

11/17/2016

Journal of Clinical Pathways

Research in Review

PD-1 Inhibitors Best Targeted Therapy for Advanced Melanoma

11/08/2016

JCP Editors

A combination of immunotherapy treatments improves survival and lowers the risk of life-threatening events for patients with late-stage melanoma compared with targeted therapy, according to a new JAMA Oncology...

A...

11/08/2016

Journal of Clinical Pathways

Research in Review

NCCN Responds to Study Findings on Financial Conflicts of Interest

11/04/2016

JCP Editors

The National Comprehensive Cancer Network (NCCN) agreed that ongoing monitoring and research regarding financial conflicts of interest (COIs) at the interface of academia, medicine, and industry is critical,...

The...

11/04/2016

Journal of Clinical Pathways

Research in Review

Standard of Care Underutilized for Cervical Cancer

11/04/2016

JCP Editors

Though proven to offer superior outcomes versus other treatment regimens, less than half of patients receive standard of care for locally advanced cervical cancer, according to a study published in Gynecologic...

Though...

11/04/2016

Journal of Clinical Pathways

Research in Review

Mixed Consensus on Cardiovascular Screening Guidelines

10/12/2016

JCP Editors

Primary care physicians play an important role in the prevention of cardiovascular disease (CVD) but still find implementation of prevention strategies challenging, which may be limiting their usage. A review of...

...

10/12/2016

Journal of Clinical Pathways

Research in Review

Clinical Pathway Improves Screening and Treatment for Osteoporosis

10/12/2016

JCP Editors

Despite the high frequency of osteoporosis, it is still underdiagnosed and undertreated in many health care settings. However, a group of Belgium researchers may have developed a clinical pathway capable of improving...

...

10/12/2016

Journal of Clinical Pathways